| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals Incorporated | $522.25 | -1.4% | $132.84B | 34.1 | 530.1% | — | Healthcare | 13.7% | 10.4% | ||
| 2 | Ascendis Pharma A/S | $266.97 | -0.4% | $16.49B | -64.5 | 229.7% | — | Healthcare | 51.7% | 135.3% | ||
| 3 | BridgeBio Pharma, Inc. | $77.91 | 0.2% | $15.26B | -20.6 | -6.2% | — | Healthcare | 79.1% | 355.2% | ||
| 4 | BioMarin Pharmaceutical Inc. | $60.35 | 2.7% | $11.61B | 33.5 | -48.3% | — | Healthcare | 5.1% | 9.9% | ||
| 5 | Corcept Therapeutics Incorporated | $94.04 | 2.7% | $10.1B | 114.7 | -69.8% | — | Healthcare | 39.2% | 12.2% | ||
| 6 | Crinetics Pharmaceuticals, Inc. | $83.53 | 98.7% | $8.81B | -16.9 | -34.6% | — | Healthcare | 187.4% | 2277.5% | ||
| 7 | PTC Therapeutics, Inc. | $89.20 | 4.4% | $7.4B | 11.5 | -135.9% | — | Healthcare | 85.9% | -53.3% | ||
| 8 | Cogent Biosciences, Inc. | $40.01 | 1.4% | $6.84B | -15.7 | -30.5% | — | Healthcare | 327.9% | — | ||
| 9 | Mirum Pharmaceuticals, Inc. | $128.31 | 5.2% | $6.44B | -273.0 | -745.9% | — | Healthcare | 154.2% | 8% | ||
| 10 | Travere Therapeutics, Inc. | $57.85 | 0.6% | $5.38B | -103.3 | 81.1% | — | Healthcare | 296% | 96% | ||
| 11 | Edgewise Therapeutics, Inc. | $43.13 | 7.6% | $4.64B | -26.5 | -7.1% | — | Healthcare | 242% | — | ||
| 12 | Amicus Therapeutics, Inc. | $14.49 | 0% | $4.55B | -164.8 | 50.9% | — | Healthcare | 139.5% | 20% | ||
| 13 | Catalyst Pharmaceuticals, Inc. | $31.49 | -0% | $3.85B | 18.7 | 10.2% | — | Healthcare | 50.3% | 11.7% | ||
| 14 | Ultragenyx Pharmaceutical Inc. | $35.87 | 6.4% | $3.53B | -6.2 | -3.9% | — | Healthcare | -9.4% | 13.3% | ||
| 15 | Disc Medicine, Inc. | $79.76 | 3.6% | $3.05B | -13.3 | -69.4% | — | Healthcare | 49.4% | — | ||
| 16 | Soleno Therapeutics, Inc. | $53.01 | 0% | $2.76B | 135.9 | 138.2% | — | Healthcare | -37.8% | — | ||
| 17 | Agios Pharmaceuticals, Inc. | $44.01 | 17.7% | $2.62B | -6.2 | -164.2% | — | Healthcare | 25% | 78.3% | ||
| 18 | BioCryst Pharmaceuticals, Inc. | $10.99 | 8.1% | $2.31B | 9.1 | -585.1% | — | Healthcare | 25.5% | 75.9% | ||
| 19 | Pharvaris N.V. | $34.59 | 4.1% | $2.26B | -10.2 | -0.7% | — | Healthcare | 92.2% | — | ||
| 20 | Harmony Biosciences Holdings, Inc. | $38.26 | 3.4% | $2.21B | 14.1 | -5.3% | — | Healthcare | 18.7% | 20.7% | ||
| 21 | Sionna Therapeutics, Inc. | $44.93 | 4.2% | $2.03B | -23.9 | -22% | — | Healthcare | 114.4% | — | ||
| 22 | Palvella Therapeutics, Inc. | $145.70 | 3.8% | $1.72B | -39.3 | 58% | — | Healthcare | 485.1% | — | ||
| 23 | Xeris Biopharma Holdings, Inc. | $8.94 | 6.8% | $1.54B | 2793.8 | 121.3% | — | Healthcare | 90.2% | 41.5% | ||
| 24 | Savara Inc. | $6.06 | -1.6% | $1.24B | -11.4 | -14.3% | — | Healthcare | 159% | — | ||
| 25 | Eton Pharmaceuticals, Inc. | $37.74 | -0.7% | $1.03B | -222.0 | 65.4% | — | Healthcare | 162.3% | 79.9% | ||
| 26 | Pharming Group N.V. | $14.46 | 1% | $1.01B | 361.5 | 186.5% | — | Healthcare | 46.4% | 33196.3% | ||
| 27 | Zevra Therapeutics, Inc. | $14.44 | 3.4% | $854M | 10.7 | 213.3% | — | Healthcare | 28.1% | 201.3% | ||
| 28 | Astria Therapeutics, Inc. | $12.58 | 0% | $718M | -7.5 | -2.4% | — | Healthcare | 102.9% | — | ||
| 29 | X4 Pharmaceuticals, Inc. | $3.94 | -2.2% | $498M | -2.1 | -313.1% | — | Healthcare | 133.1% | -71.3% | ||
| 30 | Keros Therapeutics, Inc. | $11.65 | 5.6% | $373M | 5.1 | -712.5% | — | Healthcare | -13.1% | -84.5% | ||
| 31 | Larimar Therapeutics, Inc. | $3.41 | 3.6% | $292M | -1.5 | -40.9% | — | Healthcare | 6.6% | — | ||
| 32 | Fulcrum Therapeutics, Inc. | $3.77 | 1.3% | $204M | -3.2 | -1542.9% | — | Healthcare | -46.3% | -100% | ||
| 33 | Protalix BioTherapeutics, Inc. | $2.36 | 2.6% | $190M | -28.1 | 334.9% | — | Healthcare | 60.5% | 27.8% | ||
| 34 | Rallybio Corporation | $15.67 | -0.3% | $83M | -9.9 | 82.9% | — | Healthcare | 476.1% | 1.2% | ||
| 35 | Spruce Biosciences, Inc. | $50.77 | -2.1% | $70M | -1.0 | 62.6% | — | Healthcare | 867% | -100% | ||
| 36 | Mereo BioPharma Group plc | $0.33 | 5.7% | $53M | -1.3 | 99.9% | — | Healthcare | -88.5% | — | ||
| 37 | Grace Therapeutics, Inc. | $2.51 | -0.8% | $41M | -5.3 | 46.4% | — | Healthcare | -16.3% | — | ||
| 38 | Applied Therapeutics, Inc. | $0.10 | 0% | $15M | -0.1 | 93.6% | — | Healthcare | -69.3% | 573.9% | ||
| 39 | Quoin Pharmaceuticals, Ltd. | $4.80 | 4.3% | $9M | -0.5 | 48.4% | — | Healthcare | -45.9% | — | ||
| 40 | Cadrenal Therapeutics, Inc. Common Stock | $3.23 | -3.9% | $8M | -0.5 | 39.2% | — | Healthcare | -75.1% | — | ||